Recovery of polyclonal immunoglobulins during treatment in patients ineligible for autologous stem-cell transplantation is a prognostic marker of longer progression-free survival and overall survival

1. Dávila, J.
2. González-Calle, V.
3. Escalante, F.
4. Cerdá, S.
5. Puig, N.
6. García-Sanz, R.
7. Bárez, A.
8. Montes, C.
9. López, R.
10. Alonso, J.M.
11. Aguilar, C.
12. García-Mateo, A.
13. Labrador, J.
14. Aguilera, C.
15. García-Coca, A.
16. Hernández, R.
17. Mateos, M.-V.
18. Ocio, E.M.